However, despite significant weight loss, liraglutide-treated animals displayed increased bone mass, trabecular number, and cortical thickness in the appendicular and axial skeletons, with marked improvement in bone formation parameters [55,56,57]
Moreover, a counterintuitive reduction in N-terminal pro B-type natriuretic peptide concentrations on top of weight reduction has been shown in both STEP HFpEF trials, indicating potential direct cardiac effects of the therapies
With GLP-1 (glucagon-like peptide-1 receptor agonists) medications, there are now more options available for people looking to help manage their weight and related health conditions
What are the potential benefits and risks of GLP-1s in my case
Depends on the research question
We have a relatively long wait time access to obesity care and bariatric surgery, she said